Strides Pharma 35th AGM Notice Aug 14, Rs 5/share Final Dividend

Pat Growth 25pctResults RestatedResults View source PDF Explain this filing

STAR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.5%Reaction day

₹1055.00

prior close

₹1054.10

announcement price

In-mkt

timing

Nifty Microcap 250market+0.3%-0.8% vs market

Pharmaceuticals peers, median of 165sector+0.1%-0.6% vs sector

On the reaction day the stock moved 0.8 pts less than Nifty Microcap 250 and 0.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

-0.2

15m

-0.3

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.5+0.3-0.8+0.1-0.6

Next day

-1.2-0.9-0.3-1.5+0.3

-2.1-1.5-0.6-2.1+0.0

-3.2-1.1-2.1-2.2-1.0

-1.1+0.2-1.2-1.6+0.5

-1.4-1.1-0.3-2.4+1.0

+2.0-1.2+3.2-2.6+4.6

15d

-4.7+3.1-7.8+0.3-5.0

-6.7+4.5-11.2-0.4-6.3

+16.6+4.5+12.1+0.9+15.6

-2.4-2.2-0.1-6.0+3.6

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Strides Pharma 35th AGM on Aug 14, 2026 via video conferencing. Final dividend of Rs 5 per share proposed with record date July 31. Items include Arun Kumar re-appointment, Aditya Kumar transition to Non-Executive role, and Ram Pakalapati as Executive Director for 3 years at total pay of Rs 5.04 crore per year. FY26 consolidated PAT rose to Rs 6,687 million from Rs 4,869 million. Earlier year figures restated.

Likely market impact

Voting on Rs 5/share dividend and director changes at Aug 14 AGM. FY26 consolidated PAT grew around 37 percent year on year to Rs 6,687 million.